ttopstart - Business development and strategic planning
DP Value RD Assets Collab Licensing
1. Duff & Phelps
Duff & Phelps’ valuations assist early-stage companies and
established pharmaceutical and biotech manufacturers in
structuring and executing collaboration arrangements that
meet the needs of all parties. Our valuations support
strategic planning, transaction structuring, negotiations,
financial reporting, and tax planning.
In the current environment, many early-stage companies find
themselves with a rich pipeline of potential products but have
limited resources to fund the expensive, high-risk research
and development needed to bring a product to market.
Creative forms of collaborations are being struck with
established manufacturers seeking to renew their product
pipelines. These involve shared funding of R&D, up-front,
milestone, and royalty payments, and options to acquire assets
of the development-stage company in the future.
Duff & Phelps is experienced in valuing these agreements.
Our valuations employ the Income Approach, Market
Approach, and Cost Approach. Often in valuing early stage
R&D programs, unique terms and structures make it most
appropriate to rely on the Income Approach. We access
multiple sources of industry data as well as our client’s
internal data, to ensure that the valuation employs robust and
defensible assumptions for probabilities of technical,
regulatory, and commercial success, timing, and costs.
Our models are flexible allowing assumptions to be easily
changed to address “what-if” questions. This permits the
valuation to be updated when there is new information and
as uncertainties resolve.
We deliver an independent, objective valuation that is:
yy based on a credible, transparent valuation model and
yy employs realistic, defensible, well-documented
assumptions.
Duff & Phelps’ deep industry experience includes valuations
of more than 4500 compounds, biologics, and vaccines in
various stages of clinical development and marketing over
the last 10 years. The dedicated team of professionals in
our Healthcare and Life Sciences Practice has been
involved in many of the largest transactions within the
pharmaceutical, biotech, generics, diagnostics, and device
industries, as well as performing valuations for numerous
smaller companies and startups.
Valuation of R&D Assets,
Collaborations, and
Licensing Agreements
Duff & Phelps has performed
valuations for many of the
Healthcare and Life Science
industry’s largest transactions.
